FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000596634> ?p ?o ?g. }

• W2000596634 endingPage "H115" @default.
• W2000596634 startingPage "H111" @default.
• W2000596634 abstract "We investigated the role of angiotensin II in vascular and circulating inflammatory markers in spontaneously hypertensive rats (SHR). IL-1beta, IL-6, and TNF-alpha aortic mRNA expression and plasma levels were measured in adult SHR untreated or treated with the angiotensin II receptor antagonist candesartan (2 mg.kg(-1).day(-1)) or antihypertensive triple therapy (TT; in mg.kg(-1).day(-1): 20 hydralazine + 7 type 1 hydrochlorothiazide + 0.15 reserpine) for 10 wk. Likewise, aortic expression of NF-kappaB p50 subunit precursor p105 and its inhibitor (IkappaB) were measured. Age-matched Wistar-Kyoto rats (WKY) served as normotensive reference. High blood pressure levels were associated with increased (P < 0.05) aortic mRNA expression of IL-1beta, IL-6, and TNF-alpha. Hypertension was also accompanied by increased IL-1beta and IL-6 plasma levels. No differences were observed in circulating TNF-alpha levels between SHR and WKY. SHR presented elevated aortic mRNA expression of the transcription factor NF-kappaB and reduction in its inhibitor, IkappaB. Candesartan decreased (P < 0.05) blood pressure levels, aortic mRNA expression of IL-1beta, IL-6, and TNF-alpha, and (P < 0.05) IL-1beta and IL-6 plasma concentration. However, although arterial pressure decrease was comparable for the treatments, TT only partially reduced the increments in inflammatory markers. In fact, candesartan-treated rats showed significantly lower levels of circulating and vascular inflammatory markers than TT-treated animals. The treatments increased IkappaB mRNA expression similarly. However, only candesartan reduced NF-kappaB mRNA expression. In summary, 1) SHR presented a vascular inflammatory process; 2) angiotensin II, and increased hemodynamic forces associated with hypertension, seems to be involved in stimulation of inflammatory mediators through NF-kappaB system activation; and 3) reduction of inflammatory mediators produced by candesartan in SHR could be partially due to both downregulation of NF-kappaB and upregulation of IkappaB." @default.
• W2000596634 created "2016-06-24" @default.
• W2000596634 creator A5025379419 @default.
• W2000596634 creator A5026514677 @default.
• W2000596634 creator A5026738020 @default.
• W2000596634 creator A5033127381 @default.
• W2000596634 creator A5055705954 @default.
• W2000596634 creator A5056433609 @default.
• W2000596634 creator A5071644013 @default.
• W2000596634 creator A5074304101 @default.
• W2000596634 date "2005-01-01" @default.
• W2000596634 modified "2023-10-14" @default.
• W2000596634 title "Effect of AT₁ receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-κB/IκB system" @default.
• W2000596634 cites W1969953290 @default.
• W2000596634 cites W1988550898 @default.
• W2000596634 cites W2014017210 @default.
• W2000596634 cites W2025429912 @default.
• W2000596634 cites W2043285133 @default.
• W2000596634 cites W2057635728 @default.
• W2000596634 cites W2059221487 @default.
• W2000596634 cites W2070401810 @default.
• W2000596634 cites W2072376419 @default.
• W2000596634 cites W2072470670 @default.
• W2000596634 cites W2075604884 @default.
• W2000596634 cites W2079955140 @default.
• W2000596634 cites W2082291507 @default.
• W2000596634 cites W2085137779 @default.
• W2000596634 cites W2094696331 @default.
• W2000596634 cites W2104852764 @default.
• W2000596634 cites W2105855398 @default.
• W2000596634 cites W2112157432 @default.
• W2000596634 cites W2126355774 @default.
• W2000596634 cites W2133694559 @default.
• W2000596634 cites W2147367812 @default.
• W2000596634 cites W2147600266 @default.
• W2000596634 cites W2148162374 @default.
• W2000596634 cites W2151577160 @default.
• W2000596634 cites W2153194422 @default.
• W2000596634 cites W2154360613 @default.
• W2000596634 cites W2155952282 @default.
• W2000596634 cites W2164123970 @default.
• W2000596634 cites W2165139442 @default.
• W2000596634 cites W2166469889 @default.
• W2000596634 cites W2225325855 @default.
• W2000596634 cites W2321122833 @default.
• W2000596634 cites W2328112310 @default.
• W2000596634 cites W2328397703 @default.
• W2000596634 cites W2334824368 @default.
• W2000596634 doi "https://doi.org/10.1152/ajpheart.01061.2003" @default.
• W2000596634 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15308481" @default.
• W2000596634 hasPublicationYear "2005" @default.
• W2000596634 type Work @default.
• W2000596634 sameAs 2000596634 @default.
• W2000596634 citedByCount "117" @default.
• W2000596634 countsByYear W20005966342012 @default.
• W2000596634 countsByYear W20005966342013 @default.
• W2000596634 countsByYear W20005966342014 @default.
• W2000596634 countsByYear W20005966342015 @default.
• W2000596634 countsByYear W20005966342016 @default.
• W2000596634 countsByYear W20005966342017 @default.
• W2000596634 countsByYear W20005966342018 @default.
• W2000596634 countsByYear W20005966342019 @default.
• W2000596634 countsByYear W20005966342020 @default.
• W2000596634 countsByYear W20005966342021 @default.
• W2000596634 countsByYear W20005966342022 @default.
• W2000596634 countsByYear W20005966342023 @default.
• W2000596634 crossrefType "journal-article" @default.
• W2000596634 hasAuthorship W2000596634A5025379419 @default.
• W2000596634 hasAuthorship W2000596634A5026514677 @default.
• W2000596634 hasAuthorship W2000596634A5026738020 @default.
• W2000596634 hasAuthorship W2000596634A5033127381 @default.
• W2000596634 hasAuthorship W2000596634A5055705954 @default.
• W2000596634 hasAuthorship W2000596634A5056433609 @default.
• W2000596634 hasAuthorship W2000596634A5071644013 @default.
• W2000596634 hasAuthorship W2000596634A5074304101 @default.
• W2000596634 hasBestOaLocation W20005966342 @default.
• W2000596634 hasConcept C123915805 @default.
• W2000596634 hasConcept C126322002 @default.
• W2000596634 hasConcept C134018914 @default.
• W2000596634 hasConcept C170493617 @default.
• W2000596634 hasConcept C2780036600 @default.
• W2000596634 hasConcept C2780521442 @default.
• W2000596634 hasConcept C2908929049 @default.
• W2000596634 hasConcept C71924100 @default.
• W2000596634 hasConcept C84393581 @default.
• W2000596634 hasConceptScore W2000596634C123915805 @default.
• W2000596634 hasConceptScore W2000596634C126322002 @default.
• W2000596634 hasConceptScore W2000596634C134018914 @default.
• W2000596634 hasConceptScore W2000596634C170493617 @default.
• W2000596634 hasConceptScore W2000596634C2780036600 @default.
• W2000596634 hasConceptScore W2000596634C2780521442 @default.
• W2000596634 hasConceptScore W2000596634C2908929049 @default.
• W2000596634 hasConceptScore W2000596634C71924100 @default.
• W2000596634 hasConceptScore W2000596634C84393581 @default.
• W2000596634 hasIssue "1" @default.
• W2000596634 hasLocation W20005966341 @default.
• W2000596634 hasLocation W20005966342 @default.
• W2000596634 hasLocation W20005966343 @default.

• next